North Point Portfolio Managers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$447K Sell
3,061
-50
-2% -$6.91K 0.08% 56
2026
Q2
$400K Sell
3,111
-95
-3% -$11.1K 0.07% 57
2026
Q1
$386K Sell
3,206
-600
-16% -$69.3K 0.07% 55
2025
Q4
$401K Sell
3,806
-536
-12% -$50.3K 0.07% 53
2025
Q3
$364K Hold
4,342
– – 0.06% 54
2025
Q2
$344K Hold
4,342
– – 0.06% 57
2025
Q1
$390K Buy
+4,342
New +$405K 0.07% 55
2024
Q4
– Sell
-6,942
Closed -$788K – 84
2024
Q3
$788K Buy
6,942
+5,020
+261% +$596K 0.13% 52
2024
Q2
$238K Buy
+1,922
New +$248K 0.04% 58

Other funds holding MRK

North Point Portfolio Managers's MRK Position: Q3 2026 in Review

North Point Portfolio Managers reduced its Merck (MRK) stake by 1.6% in Q3 2026, selling an estimated $6.91K and leaving 3,061 shares worth $447K. The position accounts for 0.08% of the portfolio, ranked #56.

North Point Portfolio Managers first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $788K in Q3 2024. 203 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • North Point Portfolio Managers held 3,061 shares of Merck worth $447K as of Q3 2026.
  • North Point Portfolio Managers sold 50 Merck shares in Q3 2026, an estimated $6.91K.
  • Merck made up 0.08% of North Point Portfolio Managers's portfolio in Q3 2026, its #56 holding.
  • North Point Portfolio Managers first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • North Point Portfolio Managers's Merck position peaked at $788K in Q3 2024.
  • 203 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on North Point Portfolio Managers's 13F filing for Q3 2026, filed 7 Oct 2026.